The 595-nm Wavelength Pulsed Dye Laser for Pediatric Port-Wine Birthmarks and Infantile Hemangiomas: A Systematic Review.

ABSTRACT:

Introduction

The 595-nm wavelength pulsed dye laser (PDL) is well-established in the treatment of vascular lesions. In June 2023, it received FDA clearance for the treatment of port-wine birthmarks (PWB) and infantile hemangiomas (IH) in the pediatric population.

Objective

Review the evidence regarding the efficacy, safety, and implications of using PDL for management of pediatric PWB and IH.

Methods

A systematic literature search was performed to identify peer-reviewed articles and clinical trials published between July 2002 and December 2022 in which PDL was used to treat pediatric PWB and IH.

Results

After application of criteria, 33 journal articles with 7725 total patients were included. Only 16 (0.8%) of the 2,033 patients with PWB and 11 (0.2%) of the 56

SUBMITTER: Hashemi DA 

PROVIDER: S-EPMC11776443 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature